申请人:Billedeau Roland Joseph
公开号:US08361962B2
公开(公告)日:2013-01-29
The present invention relates to the use of novel compounds of Formulae I-II,
wherein the variables R, X1, X2, X3, Y1, Y2, Y3, Z1, and Z2 are defined as described herein, which inhibit JAK and are useful for the treatment of auto-immune and inflammatory diseases.
本发明涉及使用式I-II的新化合物,其中变量R、X1、X2、X3、Y1、Y2、Y3、Z1和Z2的定义如本文所述,这些化合物抑制JAK并且对于治疗自身免疫和炎症性疾病有用。